Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron-Reference-Cited by-同舟云学术

Survival Prediction of Clear Cell Renal Cell Carcinoma Based on Gene Expression Similarity to the Proximal Tubule of the Nephron

Published:2015-12 Issue:6 Volume:68 Page:1016-1020
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Büttner Florian,Winter Stefan,Rausch Steffen,Reustle Anna,Kruck Stephan,Junker Kerstin,Stenzl Arnulf,Agaimy Abbas,Hartmann Arndt,Bedke Jens,Schwab Matthias,Schaeffeler Elke

Publisher

Elsevier BV

Subject

Urology

Reference11 articles.

1. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity;Shuch;Eur Urol,2015

2. The somatic genomic landscape of chromophobe renal cell carcinoma;Davis;Cancer Cell,2014

3. DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome;Fisel;Clin Cancer Res,2013

4. Systematic evaluation of the prognostic impact and intratumour heterogeneity of clear cell renal cell carcinoma biomarkers;Gulati;Eur Urol,2014

5. External validation of the Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear-cell renal cell carcinoma in a single European centre applying routine pathology;Zigeuner;Eur Urol,2010

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering glutamine metabolism patterns for malignancy and tumor microenvironment in clear cell renal cell carcinoma;Clinical and Experimental Medicine;2024-07-06

2. Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma;JCO Precision Oncology;2024-05

3. Integrated genomic and proteomic analyses identify PYGL as a novel experimental therapeutic target for clear cell renal cell carcinoma;Heliyon;2024-03

4. Glutaredoxin 2 Protein (Grx2) as an Independent Prognostic Factor Associated with the Survival of Colon Adenocarcinoma Patients;International Journal of Molecular Sciences;2024-01-15

5. CARD11 serves as a therapeutic biomarker for the drug therapies of ccRCC;BIOCELL;2024